126 related articles for article (PubMed ID: 2140551)
1. Reversible inhibition of human placental microsomal aromatase by CGS 18320B and other non-steroidal compounds.
Bullion KA; Osawa Y; Braun DG
Endocr Res; 1990; 16(2):255-67. PubMed ID: 2140551
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity studies of non-steroidal aromatase inhibitors: the crystal and molecular structures of CGS 16949A and CGS 18320B.
Van Roey P; Bullion KA; Osawa Y; Browne LJ; Bowman RM; Braun DG
J Enzyme Inhib; 1991; 5(2):119-32. PubMed ID: 1669441
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A.
Steele RE; Mellor LB; Sawyer WK; Wasvary JM; Browne LJ
Steroids; 1987; 50(1-3):147-61. PubMed ID: 2973160
[TBL] [Abstract][Full Text] [Related]
4. Novel aromatase inhibitors.
Bhatnagar AS; Häusler A; Schieweck K; Browne LJ; Bowman R; Steele RE
J Steroid Biochem Mol Biol; 1990 Nov; 37(3):363-7. PubMed ID: 2147860
[TBL] [Abstract][Full Text] [Related]
5. The effect of the aromatase inhibitor, rogletimide (pyridoglutethimide), on guinea pig adrenal cell steroidogenesis and placental microsomal aromatase activity: comparison with aminoglutethimide and CGS 16949A.
Newton CJ; Mehta A; Dowsett M
J Steroid Biochem Mol Biol; 1991 Nov; 39(5A):723-7. PubMed ID: 1659868
[TBL] [Abstract][Full Text] [Related]
6. In vitro potency and selectivity of the non-steroidal androgen aromatase inhibitor CGS 16949A compared to steroidal inhibitors in the brain.
Wozniak A; Holman SD; Hutchison JB
J Steroid Biochem Mol Biol; 1992 Oct; 43(4):281-7. PubMed ID: 1390279
[TBL] [Abstract][Full Text] [Related]
7. Kinetic analysis of reversible inhibition of 16alpha-hydroxyandrostenedione aromatization in human placental microsomes by suicide substrates of androstenedione aromatization.
Numazawa M; Mutsumi A; Tachibana M; Yoshimura A
Biol Pharm Bull; 2003 Jun; 26(6):890-2. PubMed ID: 12808307
[TBL] [Abstract][Full Text] [Related]
8. Inhibition and inactivation of equine aromatase by steroidal and non-steroidal compounds. A comparison with human aromatase inhibition.
Moslemi S; Seralini GE
J Enzyme Inhib; 1997 Dec; 12(4):241-54. PubMed ID: 9502046
[TBL] [Abstract][Full Text] [Related]
9. Effect of aromatase inhibitors on estrogen 2-hydroxylase in rat liver.
Purba HS; King EJ; Richert P; Bhatnagar AS
J Steroid Biochem Mol Biol; 1994 Feb; 48(2-3):215-9. PubMed ID: 8142297
[TBL] [Abstract][Full Text] [Related]
10. Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitor.
Santen RJ; Demers LM; Lynch J; Harvey H; Lipton A; Mulagha M; Hanagan J; Garber JE; Henderson IC; Navari RM
J Clin Endocrinol Metab; 1991 Jul; 73(1):99-106. PubMed ID: 1646219
[TBL] [Abstract][Full Text] [Related]
11. Potency and specificity of CGS-16949A as an aromatase inhibitor.
Santen RJ; Langecker P; Santner SJ; Sikka S; Rajfer J; Swerdloff R
Endocr Res; 1990; 16(1):77-91. PubMed ID: 2139412
[TBL] [Abstract][Full Text] [Related]
12. Biological characterization of A-ring steroids.
Johnston JO; Wright CL; Burkhart JP; Peet NP
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):623-31. PubMed ID: 8476773
[TBL] [Abstract][Full Text] [Related]
13. A comparison of methods measuring aromatase activity in human placenta and rat ovary.
Purba HS; Bhatnagar AS
J Enzyme Inhib; 1990; 4(2):169-78. PubMed ID: 2151521
[TBL] [Abstract][Full Text] [Related]
14. The new aromatase inhibitor CGS-16949A suppresses aldosterone and cortisol production by human adrenal cells in vitro.
Lamberts SW; Bruining HA; Marzouk H; Zuiderwijk J; Uitterlinden P; Blijd JJ; Hackeng WH; De Jong FH
J Clin Endocrinol Metab; 1989 Oct; 69(4):896-901. PubMed ID: 2550511
[TBL] [Abstract][Full Text] [Related]
15. Competitive inhibition of human placental aromatase by N-n-octanoylnornicotine and other nornicotine derivatives.
Bullion K; Ohnishi S; Osawa Y
Endocr Res; 1991; 17(3-4):409-19. PubMed ID: 1811989
[TBL] [Abstract][Full Text] [Related]
16. An in vitro method to determine the selective inhibition of estrogen biosynthesis by aromatase inhibitors.
Häusler A; Schenkel L; Krähenbühl C; Monnet G; Bhatnagar AS
J Steroid Biochem; 1989 Jul; 33(1):125-31. PubMed ID: 2527324
[TBL] [Abstract][Full Text] [Related]
17. Substrate specificity of the placental microsomal aromatase.
Gibb W; Lavoie JC
Steroids; 1980 Nov; 36(5):507-19. PubMed ID: 7456098
[TBL] [Abstract][Full Text] [Related]
18. Aromatase inhibition by 4-thiosubstituted-4-androstene-3,17-dione derivatives.
Abul-Hajj YJ
J Steroid Biochem; 1990 Jan; 35(1):139-43. PubMed ID: 2308324
[TBL] [Abstract][Full Text] [Related]
19. Kinetic properties of aromatase mutants Pro308Phe, Asp309Asn, and Asp309Ala and their interactions with aromatase inhibitors.
Kadohama N; Yarborough C; Zhou D; Chen S; Osawa Y
J Steroid Biochem Mol Biol; 1992 Dec; 43(7):693-701. PubMed ID: 1472461
[TBL] [Abstract][Full Text] [Related]
20. Time-dependent aromatase inactivation by 4 beta,5 beta-epoxides of the natural substrate androstenedione and its 19-oxygenated analogs.
Numazawa M; Yoshimura A; Tachibana M; Shelangouski M; Ishikawa M
Steroids; 2002 Mar; 67(3-4):185-93. PubMed ID: 11856542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
